MENU
LGHT
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

LGHT stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for LGHT with price predictions
Nov 10, 2026

LGHT in +1.26% Uptrend, advancing for three consecutive days on October 28, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LGHT advanced for three days, in 79 of 107 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on LGHT as a result. In 38 of 54 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 70 of 106 cases where LGHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.

Bearish Trend Analysis

The 10-day RSI Indicator for LGHT moved out of overbought territory on October 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In 10 of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 39 cases where LGHT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for LGHT turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 26 similar instances when the indicator turned negative. In 20 of the 26 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

LGHT broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Moderna (NASDAQ:MRNA), IQVIA Holdings (NYSE:IQV).

Industry description

The investment seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.

Market Cap

The average market capitalization across the Langar Global HealthTech ETF (LGHT) ETF is 24.7B. The market cap for tickers in the group ranges from 17.9B to 159.96B. ISRG holds the highest valuation in this group at 159.96B. The lowest valued company is SONVY at 17.9B.

High and low price notable news

The average weekly price growth across all stocks in the Langar Global HealthTech ETF (LGHT) ETF was 21%. For the same ETF, the average monthly price growth was 51%, and the average quarterly price growth was 407%. MRNA experienced the highest price growth at 10%, while DXCM experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Langar Global HealthTech ETF (LGHT) ETF was 39%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 57
Price Growth Rating: 40
SMR Rating: 71
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)
LGHT in +1.26% Uptrend, advancing for three consecutive days on October 28, 2026